Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)

Available (expanded access)

Conditions studied: SCA, Spinocerebellar Ataxias

In brief

The purpose of this expanded access protocol is to provide access to the investigational drug troriluzole in patients with spinocerebellar ataxia (SCA).

Key facts

Study ID

NCT06034886

Run by

Biohaven Pharmaceuticals, Inc.

Last updated by the study team

2026-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.